The stakes are high for aducanumab because it’s among the last potential drugs standing that targets beta amyloid, the protein that forms sticky plaques around neurons in the brains of people with Alzheimer’s. But the failure of several anti-amyloid...
In 2016, a 73-year-old woman from Medellín, Colombia, flew to Boston so researchers could scan her brain, analyze her blood, and pore over her genome. She carried a genetic mutation that had caused many in her family to develop dementia in middle age. But for decades,...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
